Royal Philips Plans €125M Share Buyback for Incentive Obligations

Royal Philips announced a strategic plan to repurchase up to 6 million shares, valued at approximately EUR 125 million, to fulfill obligations arising from its long-term incentive plans. The buyback will be conducted through forward transactions during the second and third quarters of 2025, with the company expecting to take delivery of the shares in 2027. This repurchase program aligns with authorization from the General Meeting of Shareholders and complies with Market Abuse Regulations. Analysts provide a mixed outlook on Philips' stock, with average price targets around $29.71 to $33.00 and recommendations ranging from Neutral to Outperform, reflecting potential upside from the current price near $22.80. Despite financial challenges including declining revenues and net losses, Philips continues to focus on innovation and operational improvements as key to recovery and shareholder value enhancement. The company remains a global leader in health technology, serving both consumer and professional healthcare markets.